Literature DB >> 14699124

DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.

James F Burrows1, Michael J McGrattan, Anne Rascle, Martine Humbert, Kwang-Hyun Baek, James A Johnston.   

Abstract

Previous studies have identified the DUB family of cytokine-regulated murine deubiquitinating enzymes, which play a role in the control of cell proliferation and survival. Through data base analyses and cloning, we have identified a human cDNA (DUB-3) that shows significant homology to the known murine DUB family members. Northern blotting has shown expression of this gene in a number of tissues including brain, liver, and muscle, with two transcripts being apparent (1.6 and 1.7 kb). In addition, expression was observed in cell lines including those derived from a number of hematopoietic tumors such as the Burkitt's lymphoma cell line RAJI. We have also demonstrated that DUB-3, which was shown to be an active deubiquitinating enzyme, is induced in response to interleukin-4 and interleukin-6 stimulation. Finally, we have demonstrated that constitutive expression of DUB-3 blocks proliferation and can initiate apoptosis in both IL-3-dependent Ba/F3 cells and NIH3T3 fibroblasts. These findings suggest that human DUB-3, like the murine DUB family members, is transiently induced in response to cytokines and can, when constitutively expressed, block growth factor-dependent proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699124     DOI: 10.1074/jbc.M311291200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

2.  Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (USP17) Gene Family, is a Potential Target for Epithelial-Mesenchymal Transition in High-Grade Serous Ovarian Cancer.

Authors:  Nuri Yildirim; Gizem Calibasi Kocal; Zerrin Isik; Bahadır Saatli; Ugur Saygili; Tugba Uysal; Cagnur Ulukus; Meral Koyuncuoglu; Hulya Ellidokuz; Yasemin Basbinar
Journal:  Reprod Sci       Date:  2018-09-09       Impact factor: 3.060

3.  The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells.

Authors:  Lei Han; Jing Yang; Xiuwen Wang; Qingsi Wu; Shuying Yin; Zhiyuan Li; Jing Zhang; Yue Xing; Zuojia Chen; Andy Tsun; Dan Li; Miranda Piccioni; Yu Zhang; Qiang Guo; Lindi Jiang; Liming Bao; Ling Lv; Bin Li
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

Review 4.  Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.

Authors:  Mingjing He; Zhuan Zhou; George Wu; Qianming Chen; Yong Wan
Journal:  Pharmacol Ther       Date:  2017-03-06       Impact factor: 12.310

5.  Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Eung-Ji Lee; Hey-Jin Lee; Woong-Shick Ahn; Kwang-Hyun Baek
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

6.  Steady-state kinetic studies reveal that the anti-cancer target Ubiquitin-Specific Protease 17 (USP17) is a highly efficient deubiquitinating enzyme.

Authors:  Nicole M Hjortland; Andrew D Mesecar
Journal:  Arch Biochem Biophys       Date:  2016-10-15       Impact factor: 4.013

7.  USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.

Authors:  James F Burrows; Alyson A Kelvin; Cheryl McFarlane; Roberta E Burden; Michael J McGrattan; Michelle De la Vega; Ureshnie Govender; Derek J Quinn; Karim Dib; Massimo Gadina; Christopher J Scott; James A Johnston
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

8.  The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.

Authors:  James F Burrows; Christopher J Scott; James A Johnston
Journal:  BMC Genomics       Date:  2010-04-19       Impact factor: 3.969

9.  Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.

Authors:  Caroline R Boyd; Selinda J Orr; Shaun Spence; James F Burrows; Joanne Elliott; Helen P Carroll; Kiva Brennan; Joan Ní Gabhann; Wilson A Coulter; Claire Jones; Paul R Crocker; James A Johnston; Caroline A Jefferies
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 10.  Ubiquitin Ligases and Deubiquitinating Enzymes in CD4+ T Cell Effector Fate Choice and Function.

Authors:  Awo A K Layman; Paula M Oliver
Journal:  J Immunol       Date:  2016-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.